SCN8A and epilepsy: Recently, using CRISPR/Cas9 technology, we generated a mouse line expressing the SCN8A R1620L mutation (Figure 1A), which was identified in a patient with relatively mild epilepsy and behavioral deficits (Wong et al., 2021a).